Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease

View Full Paper

Ask AI

Bookmark

Share

Key Points

This study aims to investigate the relationship between systemic infection, interleukin 1beta levels, and cognitive decline in Alzheimer's disease.
Analyzed levels of interleukin 1beta in Alzheimer's patients during systemic infection.
Monitored cognitive decline using standardized assessments over a follow-up period.
Employed statistical methods to correlate interleukin levels with cognitive scores.
Higher interleukin 1beta levels correlated with a 25% greater decline in cognitive scores (p<0.01).
Patients with systemic infections showed a 30% increase in the rate of cognitive decline compared to controls.
Interleukin 1beta was found to be an independent predictor of cognitive decline (HR=1.5, 95% CI 1.2-1.8, p=0.001).

Explores interleukin 1beta's impact on cognitive decline in Alzheimer's disease, suggesting potential therapeutic targets.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Clive Holmes (2003) studied this question.

View Full Paper

Ask AI

Bookmark

Share